Rapid weight loss from these medications can increase gallstone formation risk and potentially trigger complications in those with existing stones
Special thanks to Elaine Young and Kelly Close for their insights and collaboration on this column
We anticipate changes at the national level as more countries formally recognise obesity as a chronic disease and move toward structured reimbursement frameworks for obesity medications
While many users tolerate the medication well, individual responses can differ
The summary table compares the primary receptor targets, vascular effects, and heart-rate responses observed at low versus high doses of IV acetylcholine
Ausncia de ensaios clnicos humanos confiveis: At o momento, no existem estudos cientficos de grande escala que comprovem eficcia, segurana, dose adequada ou efeitos a longo prazo do BPC-157 em humanos